Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $3.89 Analyst target: $9.33 Upside: 139.85%
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and marketing various products to address unmet medical needs in the United States and internationally. The company is headquartered in Warren, New Jersey.
See the full interactive analysis & chart →Informational only — not investment advice.